GLCCI1 and Cowden syndrome 1: Several studies have focused on identifying genetic variants that impact the efficacy of CS treatment in various pathologies, and two SNPs in the corticotrophin-releasing hormone receptor 1 (CRHR1) and in the glucocorticoid-induced transcript 1 (GLCCI1) genes, have been identified.